Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells
Open Access
- 26 April 2012
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 11 (1) , 25
Abstract
Background: Metastatic melanoma is a lethal skin cancer and its incidence is rising every year. It represents a challenge for oncologist, as the current treatment options are non-curative in the majority of cases; therefore, the effort to find and/or develop novel compounds is mandatory. Pemetrexed (Alimta®, MTA) is a multitarget antifolate that inhibits folate-dependent enzymes: thymidylate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyltransferase, required for de novo synthesis of nucleotides for DNA replication. It is currently used in the treatment of mesothelioma and non-small cell lung cancer (NSCLC), and has shown clinical activity in other tumors such as breast, colorectal, bladder, cervical, gastric and pancreatic cancer. However, its effect in human melanoma has not been studied yet. Results: In the current work we studied the effect of MTA on four human melanoma cell lines A375, Hs294T, HT144 and MeWo and in two NSCLC cell lines H1299 and Calu-3. We have found that MTA induces DNA damage, S-phase cell cycle arrest, and caspase- dependent and –independent apoptosis. We show that an increment of the intracellular reactive oxygen species (ROS) and p53 is required for MTA-induced cytotoxicity by utilizing N-Acetyl-L-Cysteine (NAC) to blockage of ROS and p53-defective H1299 NSCLC cell line. Pretreatment of melanoma cells with NAC significantly decreased the DNA damage, p53 up-regulation and cytotoxic effect of MTA. MTA was able to induce p53 expression leading to up-regulation of p53-dependent genes Mcl-1 and PIDD, followed by a postranscriptional regulation of Mcl-1 improving apoptosis. Conclusions: We found that MTA induced DNA damage and mitochondrial-mediated apoptosis in human melanoma cells in vitro and that the associated apoptosis was both caspase-dependent and –independent and p53-mediated. Our data suggest that MTA may be of therapeutic relevance for the future treatment of human malignant melanoma.Keywords
This publication has 45 references indexed in Scilit:
- Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by ROS-Dependent ERK and JNK ActivationPLOS ONE, 2010
- HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responsesProceedings of the National Academy of Sciences, 2009
- MiR-15a and miR-16-1 cluster functions in human leukemiaProceedings of the National Academy of Sciences, 2008
- A role for caspase 2 and PIDD in the process of p53-mediated apoptosisProceedings of the National Academy of Sciences, 2008
- Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cellsAmerican Journal of Physiology-Renal Physiology, 2007
- Nitric oxide, mitochondrial hyperpolarization, and T cell activation☆Free Radical Biology and Medicine, 2007
- mir-29 regulates Mcl-1 protein expression and apoptosisOncogene, 2007
- Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosisLeukemia, 2007
- Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2Molecular Cancer Therapeutics, 2007
- Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunityTrends in Immunology, 2004